Age-adjusted mean and median total healthcare costs (2018 CAD) and incremental cost differences were calculated by screening outcome and compared by recommendation using regression models. Healthcare costs were compared overall and 1 year after a false positive (n = 46,081) s...
Reduction in late-stage breast cancer incidence in the mammography era: implications for overdiagnosis of invasive cancer. Cancer. 2014;120(17):2649-2656.PubMedGoogle ScholarCrossref 51. Carles M, Vilaprinyo E, Cots F, et al. Cost-effectiveness of early detection of breast cancer in ...
Second, there were concerns about potential biases in the US OECD data because the data were limited to a subset of states and were based on the Healthcare Utilization and Cost Project, which excludes deaths occurring outside the hospital. Consequently, we performed direct comparisons of 30-day ...
benefits (decreased cancer-related death and morbidity) and the harms (potential for overdiagnosis, false positives, false negatives, anxiety, and cost of care) of breast cancer screening.SummaryThere are multiple organizations with recommendations for breast cancer screening in women at average risk. ...
Age-adjusted mean and median total healthcare costs (2018 CAD) and incremental cost differences were calculated by screening outcome and compared by recommendation using regression models. Healthcare costs were compared overall and 1 year after a false positive (n = 46,081) screening mammogram and...